期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature 被引量:7
1
作者 Mozhgan Rezaei Kanavi masoud soheilian +1 位作者 Sayed Bagher Hosseini Amir A. Azari 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2014年第3期577-581,共5页
AIM:To report the cytology results of 25-gauge transconjunctival(25G-TSV)diagnostic vitrectomy in cases suspicious for intraocular lymphoma(IOL),and compare the results to those reported in the literature.METHODS:Clin... AIM:To report the cytology results of 25-gauge transconjunctival(25G-TSV)diagnostic vitrectomy in cases suspicious for intraocular lymphoma(IOL),and compare the results to those reported in the literature.METHODS:Clinical and cytopathological records of 18vitreous biopsy specimens obtained via 25G-TSV diagnostic vitrectomy in 12 patients suspicious for IOL were reviewed retrospectively.A review of the literature in regards to the diagnostic yields of vitreous specimens obtained via 25-gauge and 20-gauge diagnostic vitrectomy in suspected cases of IOL was performed.RESULTS:Eighteen eyes from 12 patients with clinical suspicion of IOL underwent diagnostic 25G-TSV.The cytopathological investigations demonstrated IOL in 15eyes(83.3%).Vitreous analysis was non-diagnostic in 3eyes(16.7%).CONCLUSION:Twenty-five-gauge diagnostic vitrectomy yields adequate sample for cytological evaluation of the vitreous in cases suspicious for IOL.The diagnostic results of the 25G-TSV in the current study are superior to those reported for 20-gauge vitrectomy but equivalent to those reported for 25G-TSV in the published literature. 展开更多
关键词 25-gauge vitrectomy 20-gauge vitrectomy intraocular lymphoma
下载PDF
玻璃体腔组织纤溶酶原激活剂治疗玻璃体黄斑粘连(英文) 被引量:3
2
作者 Saeed Karimi masoud soheilian +1 位作者 Homayoun Nikkhah Azadeh Haseli Mofrad 《国际眼科杂志》 CAS 北大核心 2018年第2期219-225,共7页
目的:评估仅玻璃体腔注射组织纤溶酶原激活剂(TPA)对玻璃体黄斑牵引以及玻璃体腔注射TPA和贝伐单抗对视网膜血管疾病的改善作用。方法:前瞻性研究。对24例24眼患者进行干预性系统研究。其中5眼玻璃体黄斑牵引综合征(VMT),19眼视网膜血... 目的:评估仅玻璃体腔注射组织纤溶酶原激活剂(TPA)对玻璃体黄斑牵引以及玻璃体腔注射TPA和贝伐单抗对视网膜血管疾病的改善作用。方法:前瞻性研究。对24例24眼患者进行干预性系统研究。其中5眼玻璃体黄斑牵引综合征(VMT),19眼视网膜血管疾病包括:糖尿病黄斑水肿(DME)眼,糖尿病性玻璃体出血(VH)眼,视网膜中央静脉阻塞(CRVO)和新生血管年龄相关性黄斑变性眼(AMD)。在注射前及注射1mo后分别进行视力,B超和OCT检查。3眼VMT接受玻璃体腔单次注射TPA50μg,2眼接受100μg注射。19例视网膜血管疾病患者接受玻璃体腔组织纤溶酶原激活剂(50μg)和贝伐单抗(1.25 mg)联合治疗。结果:纳入病例中男性10眼视网膜血管疾病和VMT患者平均年龄分别为56.8y和60.4y。纳入病例中男性10眼(41.7%),女性14眼(58.3%)。22眼(91.7%)晶状体眼,2眼(8.3%)人工晶状体眼。VMT和视网膜血管疾病的玻璃体后部脱离(PVD)分别为0(0/5)和57.8%(11/19)(P=0.04)。在改善最佳矫正视力(BCVA)和降低黄斑中心凹厚度(CMT)方面,与无PVD眼相比,有PVD眼改善更多。结论:在VMT患者中,单独玻璃体腔内注射TPA不能成功诱导玻璃体后部完全脱离。玻璃体腔联合注射TPA和贝伐单抗可引起视网膜血管疾病患者玻璃体后部脱离,提高最佳矫正视力以及降低黄斑中心凹厚度。 展开更多
关键词 贝伐单抗 玻璃体后部脱离 组织纤维蛋白溶酶原激活剂
下载PDF
活动性葡萄膜炎引起暂时性屈光度变化(英文)
3
作者 Mahsa Zameni Homayoun Nikkhah +3 位作者 Safa Rahmani Alireza Ramezani Mehdi Yaseri masoud soheilian 《国际眼科杂志》 CAS 北大核心 2019年第10期1637-1642,共6页
目的:评估活动性葡萄膜炎对屈光不正变化的影响。方法:这是一项前瞻性队列研究,纳入66例88眼活动性葡萄膜炎患者。受试者根据其疾病活动的解剖位置分为前、中、后和全葡萄膜炎。在活动期和静止期均行睫状肌麻痹验光,并对结果进行比较。... 目的:评估活动性葡萄膜炎对屈光不正变化的影响。方法:这是一项前瞻性队列研究,纳入66例88眼活动性葡萄膜炎患者。受试者根据其疾病活动的解剖位置分为前、中、后和全葡萄膜炎。在活动期和静止期均行睫状肌麻痹验光,并对结果进行比较。结果:活动性前非肉芽肿性葡萄膜炎的球镜变化导致平均-0.25(0.77)D(95%CI:-0.5~0)的近视转变(P=0.039),在活动性中层葡萄膜炎中,平均+0.39(0.8)D(95%CI:0.09~0.69)的远视转变(P=0.003)。活动性中层葡萄膜炎的等效球镜的变化导致远视转变[+0.43(0.94)D,95%CI:0.08~0.79,P=0.005]。柱镜仅在全色素膜炎时有明显改变[-0.3(0.39)D,95%CI:-0.58^-0.02,P=0.043]。在多元分析中,我们发现疾病活动过程(急性与复发)和疾病活动的解剖位置对等效球镜变化具有统计学意义(分别为P=0.003和P=0.004)结论:活动性葡萄膜炎对屈光度有重要影响,该变化取决于具体的炎症发生部位。 展开更多
关键词 前葡萄膜炎 中间葡萄膜炎 后葡萄膜炎 全葡萄膜炎 屈光不正
下载PDF
Safety threshold of intravitreal clonidine in rabbit's eyes
4
作者 Homayoun Nikkhah Kiumars Heidari Garfami +3 位作者 Mozhgan Rezaei Kanavi Ebrahim Mohammad Nashtaei Saeed Karimi masoud soheilian 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第1期25-30,共6页
AIM: To determine the safe dose of intravitreal clonidine(IVC), a potential drug for neuroprotection and angiogenesis inhibition in rabbits. METHODS: A total of 28 rabbits were divided into four groups. Three grou... AIM: To determine the safe dose of intravitreal clonidine(IVC), a potential drug for neuroprotection and angiogenesis inhibition in rabbits. METHODS: A total of 28 rabbits were divided into four groups. Three groups received IVC with concentrations of 15(Group A), 25(Group B), and 50(Group C) g/0.1 m L and the control group(Group D) received 0.1 m L balanced salt solution(BSS). To investigate IVC safety, electroretinography(ERG) was performed at baseline, then at 1, 4 and 8 wk after injection. After last ERG, all rabbits were euthanized, their eyes were enucleated and subjected to routine histopathological evaluation, immunohistochemistry for glial fibrillary acidic protein(GFAP) and terminal deoxynucleotidyl transferase d UTP nick end labeling(TUNEL) test.RESULTS: Based on ERG, histopathology, GFAP and TUNEL assay findings, 15 g IVC was determined as the safe dose in rabbit eyes. While, the results of routine histopathology and TUNEL assay were unremarkable in all groups, toxic effects attributed to 25 and 50 g IVC were demonstrated by ERG and GFAP tests. CONCLUSION: Totally 15 g clonidine is determined as the safe dose for intravitreal injection in rabbits. Contribution of IVC in neuroprotection and inhibition of angiogenesis deserve more studies. 展开更多
关键词 clonidine intravitreal injection electroretinography glial fibrillary acidic protein TUNEL assay
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部